TP53 and neoplasm: It activates the Ras/Raf/mitogen-activated protein (MAP) kinase pathway, which is involved in hepatocarcinogenesis, and interacts with the tumor protein 53 gene (TP53), interfering with its function as a tumor suppressor (Di Bisceglie, 2009).